{"id":16579,"date":"2011-05-09T15:55:19","date_gmt":"2011-05-09T13:55:19","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/efekt-pr-ponownie-dla-novartis\/"},"modified":"2011-05-09T15:55:19","modified_gmt":"2011-05-09T13:55:19","slug":"efekt-pr-ponownie-dla-novartis","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/efekt-pr-ponownie-dla-novartis.html","title":{"rendered":"Efekt PR ponownie dla Novartis"},"content":{"rendered":"<p>Agencja wygra\u0142a przetarg na prowadzanie kampanii PR na rzecz dw&oacute;ch lek&oacute;w OTC: Fenistil \u017bel w wi\u0119kszej pojemno\u015bci 50g i Lamisilatt1.<\/p>\n<p>Umowa zosta\u0142a podpisana na okres p&oacute;\u0142 roku.<\/p>\n<p>Kampanii PR dla Fenistil \u017bel 50 g b\u0119dzie prowadzona w szczeg&oacute;lno\u015bci w prasie parentingowej, kobiecej, poradnikowej oraz w internecie. Kampania zostanie uzupe\u0142niona dzia\u0142aniami reklamowym w magazynach parentingowych. Zakupem medi&oacute;w zajmuje si\u0119 dom mediowy MEC.<\/p>\n<p>Kampanii na rzecz Lamisilatt1, skierowanej do prasy poradnikowej, zdrowotnej i o tematyce sportowej, towarzyszy\u0107 b\u0119d\u0105 zintensyfikowane dzia\u0142ania w internecie oraz akcja specjalna, skierowana do u\u017cytkownik&oacute;w popularnych sieci fitness i park&oacute;w wodnych.<\/p>\n<p><em>Efekt Public Relations od 7 lat dzia\u0142a na rynku polskim \u015bwiadcz\u0105c us\u0142ugi z zakresu Public Relations. W zakresie dzia\u0142a\u0144 agencji znajduj\u0105 si\u0119: media relations i PR produktu, organizacja imprez specjalnych, PR korporacyjny, e-pr i social media, zakup medi&oacute;w. W gronie klient&oacute;w agencji znajduj\u0105 si\u0119 m.in. firmy Novartis, Gedeon Richter, Pharmena, Galderma, Turek Polska, Nuxe Polska.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Agencja Efekt PR kontynuuje wsp&oacute;\u0142prace z mi\u0119dzynarodowym koncernem farmaceutycznym Novartis Polska.","protected":false},"author":1,"featured_media":16580,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[],"tags":[1938],"class_list":{"0":"post-16579","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"tag-efekt-pr","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/16579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=16579"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/16579\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/16580"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=16579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=16579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=16579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}